Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2005
03/30/2005CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1600783A Imidazopyridine derivatives
03/30/2005CN1194816C Method for preparing piperazine and trivinyl-diamne molecular sieve catalyst
03/29/2005US6872825 Active materials; detectors; libraries
03/29/2005US6872746 Isomeric fused pyrrolocarbazoles and isoindolones
03/29/2005US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/29/2005US6872720 Pyrazolo-triazine derivatives as ligands for gaba receptors
03/29/2005US6872714 Methods to modulate conditions mediated by the CXCR4 receptor
03/29/2005US6872699 Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein
03/29/2005US6872477 OLEDs doped with phosphorescent compounds
03/29/2005CA2335186C Pyrrolo[2,3-d]pyrimidine compounds
03/29/2005CA2280447C Pyrrolo¬1,2-a|pyrazine derivatives as 5ht1a ligands
03/24/2005WO2005026169A1 Ceratamines a and b, and analogues, syntheses and pharmaceutical compositions thereof
03/24/2005WO2005026168A1 Method for preparing cucurbiturils
03/24/2005WO2005026162A1 Gyrase inhibitors
03/24/2005WO2005026161A1 Antibacterial agents
03/24/2005WO2005026126A1 Crf antagonists and heterobicyclic compounds
03/24/2005WO2005025681A2 A system for and a method of manufacturing personal golf putters
03/24/2005WO2005025315A1 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests
03/24/2005WO2005025293A2 Fused ring heterocycles as potassium channel modulators
03/24/2005WO2005019220A3 Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity
03/24/2005WO2005011597A3 Compounds and compositions as protein kinase inhibitors
03/24/2005WO2005000806A3 Ligands for nicotinic acetylcholine receptors, and methods of making and using them
03/24/2005WO2004113335A3 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
03/24/2005WO2004106343A3 Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
03/24/2005WO2004019283A3 Methods for regulating transcription by targeting quadruplex dna
03/24/2005WO2004007500A8 Novel diketopyrrolopyrrole pigments
03/24/2005WO2003082208A8 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
03/24/2005WO2003019621A3 Convergent synthesis of multiporphyrin light-harvesting rods
03/24/2005US20050065304 Monomer having rotaxane structure and polymers and processes for production of both
03/24/2005US20050065211 Ester derivatives
03/24/2005US20050065178 Substituted diazabicycloakane derivatives
03/24/2005US20050065169 Heteroaryl-fused pyrimidinyl compounds as anticancer agents
03/24/2005US20050065168 Dissolving in solvent; precipitation; isolation; sleep disorders; antiepileptic agents; muscle relaxants
03/24/2005US20050065167 6-Aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents
03/24/2005US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
03/24/2005US20050065153 Antiinflamamtory agents; respiratory system disorders; autoimmune disease
03/24/2005CA2539160A1 Antibacterial agents
03/24/2005CA2538829A1 Ceratamines a and b, and analogues, syntheses and pharmaceutical compositions thereof
03/24/2005CA2538242A1 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests
03/24/2005CA2538026A1 Crf antagonists and heterobicyclic compounds
03/24/2005CA2537860A1 Gyrase inhibitors
03/24/2005CA2537843A1 Method for preparing cucurbiturils
03/24/2005CA2536633A1 Fused ring heterocycles as potassium channel modulators
03/23/2005EP1515973A1 Porphyrin-polyamine conjugates for cancer therapy
03/23/2005EP1515971A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
03/23/2005EP1515968A2 Quinuclidine derivatives and pharmaceutical compositions containing the same
03/23/2005EP1515965A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
03/23/2005EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
03/23/2005EP1515719A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
03/23/2005EP1404319A4 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
03/23/2005EP1212384A4 Selectively light-absorptive material, coating composition containing the same, and filter manufactured using the coating composition for color displays
03/23/2005EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
03/23/2005EP0723398B1 Superoxide dismutase mimetics
03/23/2005CN1599737A Ring fused pyrazole derivatives
03/23/2005CN1597668A Biamido heterocyclic derivative with antitumour activity and its preparation method and use
03/23/2005CN1194001C Synthesis of monocrystal porphyrin
03/23/2005CN1194000C Metallophenyl cyclopentadienyl phthalocyanine derivative, its preparation method and application
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6870053 Useful in treatment or prophylaxis of viral infections, for example, human immunodeficiency virus and hepatitis B virus
03/22/2005US6869971 UCS1025 derivatives
03/22/2005US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine)
03/22/2005US6869956 Such as 4-(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline; kits; treating arthritis, psoriasis, inflammatory bowel disease, autoimmune diseases and neurodegenerative diseases among others
03/22/2005US6869955 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
03/22/2005US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer
03/22/2005US6869946 For therapy of disease or condition in a mammal, wherein the alpha 7 nicotinic acetylcholine receptor is implicated and for therapy of diseases where there is a sensory-gating deficit in a mammal
03/22/2005US6869943 Sorbitol dehydrogenase inhibitors
03/22/2005US6869589 Cryptate compounds and methods for diagnosis and therapy
03/22/2005US6869466 Cucurbiturils and method for binding gases and volatiles using cucurbiturils
03/22/2005CA2330092C Benzimidazole compounds as orl1-receptor agonists
03/22/2005CA2178219C Substituted morpholine derivatives and their use as therapeutic agents
03/22/2005CA2125189C Pyropheophorbides and their use in photodynamic therapy
03/17/2005WO2005023816A2 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compouds and uses thereof
03/17/2005WO2005023815A2 Neuroprotective bicyclic compounds and methods for their use
03/17/2005WO2005023814A1 Synthesis of protected pyrrolobenzodiazepines
03/17/2005WO2005023813A1 Zaleplon synthesis
03/17/2005WO2005023812A2 Piperazines as oxytocin agonists
03/17/2005WO2005023807A2 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists
03/17/2005WO2005023806A2 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands
03/17/2005WO2005023760A2 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics
03/17/2005WO2005023246A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/17/2005WO2005004808A3 TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS
03/17/2005WO2004106294A3 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
03/17/2005WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
03/17/2005US20050059823 quinazolinone compounds such as 2-cyclopropyl-4-oxo-3-((p-fluorobenzyl)carbonylamino)-7-fluoro-1,2-dihydroquinazoline; brain and nervous system disorders such as mood disorders or neuropathic pain
03/17/2005US20050059724 Novel cyanopyrrolidides, process for their preparation and their use as medicaments
03/17/2005US20050059716 Novel bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
03/17/2005US20050059699 N-acylated lipophilic amino acid derivatives
03/17/2005US20050059687 Modulators of ATP-Binding Cassette transporters
03/17/2005US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors
03/17/2005US20050059662 Substituted quinazolinone compounds
03/17/2005US20050059650 1H-pyrazolo[3,4-d]pyrimidine derivatives as antidiabetic and antiobesity agent
03/17/2005US20050059628 Modulation of beta-catenin/TCF-activated transcription
03/17/2005US20050058604 Phthalamide-lanthanide complexes for use as luminescent markers
03/17/2005CA2537883A1 Substituted bicyclic quinazolin-4-ylamine derivatives
03/17/2005CA2537829A1 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands
03/17/2005CA2537736A1 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compounds and uses thereof
03/17/2005CA2537677A1 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics
03/17/2005CA2537097A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 573